Maintaining patents protecting biologics or small-molecule drugs

A look at the maintenance rates of US patents protecting FDA-approved biologics and small molecules.

Saved in:
Bibliographic Details
Published in:Nature biotechnology 2012-01, Vol.30 (1), p.50-53
Main Authors: Marimuthu, Ganesan, Kumari, Sangita, Kandasamy, Muthukrishnakumar, Raghunathan, Srivatsan, Saberwal, Gayatri
Format: Article
Language:English
Subjects:
631/61/51
631/92/613
706/648/270
Agriculture
Bioinformatics
Biological and medical sciences
Biological products
Biological Products - therapeutic use
Biomedical and Life Sciences
Biomedical Engineering/Biotechnology
Biomedicine
Biotechnology
Drug Industry - economics
Drug Industry - legislation & jurisprudence
Drugs
FDA approval
Fees & charges
Fundamental and applied biological sciences. Psychology
Humans
Legislation, Drug - economics
Legislation. General informations
Life Sciences
Patents as Topic - legislation & jurisprudence
Pharmaceutical Preparations
United States
United States Food and Drug Administration
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A look at the maintenance rates of US patents protecting FDA-approved biologics and small molecules.
ISSN:1087-0156
1546-1696
DOI:10.1038/nbt.2082